Y-Intercept (HK)’s XBiotech XBIT Stock Holding History

Y-Intercept (HK)’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-47,885	Closed	-$142K	–	2112
2025 Q2	$142K	Buy	+47,885	New	+$139K	﹤0.01%	1503
2024 Q2	–	Sell	-18,043	Closed	-$147K	–	1990
2024 Q1	$147K	Buy	+18,043	New	+$103K	0.01%	1206

Other funds holding XBIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Y-Intercept (HK)'s XBIT Position: Q3 2025 in Review

Y-Intercept (HK) sold out of XBiotech (XBIT) in Q3 2025, closing a stake of 47,885 shares — an estimated $142K sold.

Y-Intercept (HK) first reported a position in XBIT in Q1 2024 and held it in 2 quarters. The position peaked at $147K in Q1 2024. 48 funds tracked by Wall St. Rank hold XBIT as of Q3 2025.

Y-Intercept (HK) reported no remaining XBiotech position as of Q3 2025 after selling out during the quarter.
Y-Intercept (HK) sold 47,885 XBiotech shares in Q3 2025, an estimated $142K.
Y-Intercept (HK) first reported a position in XBiotech in Q1 2024 and held it in 2 quarters.
Y-Intercept (HK)'s XBiotech position peaked at $147K in Q1 2024.
48 funds tracked by Wall St. Rank held XBiotech as of Q3 2025.

Based on Y-Intercept (HK)'s 13F filing for Q3 2025, filed 31 Oct 2025.